Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Adm Policy Ment Health. 2020 May;47(3):451–467. doi: 10.1007/s10488-019-01004-2

Table 5:

Inverse Propensity of Treatment Weighted Comparison of PTSD Symptomatic Outcomes for Patients Completing 8 or More Sessions of Evidence-Based Psychotherapy for PTSD with Aligned PTSD Checklist Measurement, FY 2008–2013, by Quality Standard

Quality Standard (A) 8 (B) 8 ST (C) 8 ST 14W A versus B A versus C B versus C
n=303 n=549 n=1,200 P E P E P E
Baseline PCL, mean (SD) 64.2 (11.0) 63.6 (10.1) 63.6 (10.0) 0.5383 0.4417 0.9994
Change in PCL, mean (SD) −7.1 (13.2) −8.6 (14.2) −9.3 (13.0) 0.1627 1.45 0.0101 1.60 0.3757 1.26
10-Poing Drop on PCL plus LOD, % (n) 13.8 (43) 21.4 (115) 23.3 (285) 0.0274 2.47 0.0004 2.77 0.4346 1.40

Note. E-value indicates the he minimum strength of association on the risk ratio scale that an unmeasured confounder would need to have with both the exposure and the outcome, conditional on the measured covariates, to fully explain away a specific exposure-outcome association; LOD=loss of diagnosis; BOLD=p<0.0167.